Disorder of magnesium transport

Summary

Disorder of magnesium transport (MONDO:0017765) is a disease. A subtype of disorder of mineral absorption and transport — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	disorder of magnesium transport
Mondo ID	MONDO:0017765
Orphanet	309848
UMLS	C5681030
MedGen	1842842
GARD	0021357
Is cancer (heuristic)	no

Also known as: inborn error of magnesium ion transport · inborn magnesium ion transport disorder · rare inborn error of magnesium ion transport

Disease family

This is a subtype of disorder of mineral absorption and transport. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › inborn errors of metabolism › disorder of metabolite absorption and transport › disorder of mineral absorption and transport › disorder of magnesium transport

Related subtypes (4): disorder of copper metabolism, disorder of iron metabolism and transport, disorder of zinc metabolism, disorder of manganese transport

Subtypes (1): familial primary hypomagnesemia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.